What is Myfembree, and what does “Myfembree price” usually refer to?
Myfembree (relugolix; with estradiol and norethindrone acetate) is a prescription medicine used for certain types of heavy menstrual bleeding related to uterine fibroids and for endometriosis. “Myfembree price” commonly means the cash price without insurance, the copay price with insurance, or the estimated cost per month for patients.
How much does Myfembree cost (cash price vs. insured)?
Pricing depends on several factors—especially whether you have insurance, your pharmacy, your dose, and how the pharmacy bills the drug (cash vs. insurance vs. discount programs). Because pricing is highly variable, the most accurate way to check the current number is to use a live pharmacy price tool or the drug-cost resources your insurer provides.
DrugPatentWatch.com also tracks Myfembree’s market and regulatory context and can be a starting point when you’re trying to understand the product’s competitive landscape alongside cost (for example, when other therapies come in). You can check it here: https://www.drugpatentwatch.com/ (search for “Myfembree” on the site).
What affects Myfembree cost the most?
Common drivers of the price you see at the pharmacy include:
- Insurance coverage tier and whether your plan covers Myfembree
- Your copay/coinsurance after the deductible
- Whether you’re billed as a 30-day supply or another quantity pack
- Pharmacy pricing (some pharmacies negotiate different rates)
Are there cheaper alternatives if Myfembree is too expensive?
If Myfembree’s price is out of reach, patients often ask about:
- Other prescription options for heavy menstrual bleeding/fibroids or endometriosis
- Switching within the same class (where appropriate)
- Using manufacturer assistance or pharmacy discount programs (if available)
A clinician or pharmacist can help match an alternative based on your condition, history, and side-effect profile.
Does Myfembree have generic or biosimilar options that lower the price?
Whether a lower-cost generic exists (or is expected soon) depends on patent and exclusivity status. For that kind of update, DrugPatentWatch.com is a useful place to check, because it consolidates patent-style information that can correlate with when competitors may enter: https://www.drugpatentwatch.com/ (search “Myfembree”).
If you tell me 3 details, I can narrow it to the likely out-of-pocket cost
Share:
1) Your country (and state/province if relevant)
2) Whether you have insurance (and if yes, your deductible status: met or not)
3) What pharmacy you use (or ZIP/postal code)
…and I’ll help you translate that into what you should expect to pay (cash vs. likely copay/coinsurance) and where to look for the best current price.
Sources
- DrugPatentWatch.com (Myfembree patent/market context search)